2Xideas AG Has $5.25 Million Stake in Intuitive Surgical, Inc. $ISRG

2Xideas AG lowered its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 14.1% in the 2nd quarter, HoldingsChannel.com reports. The fund owned 9,662 shares of the medical equipment provider’s stock after selling 1,586 shares during the quarter. 2Xideas AG’s holdings in Intuitive Surgical were worth $5,250,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. Tobam boosted its holdings in Intuitive Surgical by 666.7% in the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 40 shares in the last quarter. Kilter Group LLC bought a new stake in Intuitive Surgical during the 2nd quarter worth approximately $27,000. TD Capital Management LLC raised its stake in shares of Intuitive Surgical by 300.0% in the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 45 shares during the last quarter. 1248 Management LLC purchased a new stake in shares of Intuitive Surgical in the first quarter worth approximately $30,000. Finally, Princeton Global Asset Management LLC bought a new position in shares of Intuitive Surgical in the second quarter valued at approximately $30,000. 83.64% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

ISRG has been the subject of a number of analyst reports. Jefferies Financial Group increased their price target on Intuitive Surgical from $550.00 to $560.00 and gave the company a “hold” rating in a research report on Wednesday, October 22nd. Piper Sandler upped their target price on shares of Intuitive Surgical from $595.00 to $610.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 22nd. Rothschild & Co Redburn raised their price target on shares of Intuitive Surgical from $610.00 to $615.00 and gave the company a “buy” rating in a research report on Thursday, October 23rd. Hsbc Global Res upgraded shares of Intuitive Surgical to a “strong-buy” rating in a research note on Thursday, October 23rd. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Intuitive Surgical in a research note on Friday, October 31st. Two equities research analysts have rated the stock with a Strong Buy rating, seventeen have issued a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $607.17.

Intuitive Surgical Stock Performance

ISRG stock opened at $566.89 on Tuesday. The company has a market capitalization of $203.22 billion, a PE ratio of 74.99, a price-to-earnings-growth ratio of 5.29 and a beta of 1.68. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00. The company’s 50 day moving average price is $521.15 and its two-hundred day moving average price is $505.21.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, beating the consensus estimate of $1.99 by $0.41. The company had revenue of $2.51 billion for the quarter, compared to analyst estimates of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The firm’s quarterly revenue was up 22.9% compared to the same quarter last year. During the same quarter last year, the firm earned $1.84 EPS. On average, research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Buying and Selling

In related news, insider Gary S. Guthart sold 22,806 shares of the stock in a transaction dated Monday, December 1st. The stock was sold at an average price of $570.89, for a total transaction of $13,019,717.34. Following the completion of the sale, the insider directly owned 2,694 shares in the company, valued at $1,537,977.66. This represents a 89.44% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Craig H. Barratt sold 750 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total value of $435,000.00. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 108,939 shares of company stock worth $60,757,995 in the last 90 days. 0.70% of the stock is currently owned by company insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.